Nature News

Lack of p53 triggers TNO-dependent systemic irritation and results in metastasis of breast most cancers

1.

Diakos, C.I., Charles, Ok.A., McMillan, D.C. and Clarke, S.J. Most cancers Irritation and Therapy Efficacy. Lancet Oncol. 15, e493 to e503 (2014).

2

McAllister, S.S. & Weinberg, R. A. The tumor-induced systemic surroundings as a vital regulator of most cancers development and metastasis. Nat. Cell Biol. 16: 717-727 (2014).

three

Templeton, A. J. et al. Prognostic function of the neutrophil / lymphocyte ratio in strong tumors: systematic assessment and meta-analysis. J. Natl. Most cancers Inst. 106, July 12, 2014 (2014).

four

Coffelt, S. B., Wellenstein, M. & Visser, Ok. E. Neutrophils in most cancers: impartial, no extra. Nat. Rev. Most cancers 16, 431-446 (2016).

5

Coffelt, S.B. et al. Γδ T cells and IL-17 producing neutrophils conspire to advertise metastasis of breast most cancers. Nature 522, 345-348 (2015).

6

Kowanetz, M. et al. Granulocyte colony stimulating issue promotes pulmonary metastasis by mobilizing Ly6G + Ly6C + granulocytes. Proc. Natl Acad. Sci. USA 107, 21248-21255 (2010).

7.

Bald, T. et al. The ultraviolet-induced irritation promotes angiotropism and metastasis in melanoma. Nature 507, 109-113 (2014).

eight

Wculek, S.Ok. and Malanchi, I. Neutrophils help the pulmonary colonization of breast most cancers cells on the origin of metastases. Nature 528, 413-417 (2015).

9

Park, J. et al. Most cancers cells induce extracellular extracellular DNA traps that help metastasis. Sci. Trad. Med. eight, 361ra138 (2016).

ten.

Steele, C. W. et al. Inhibition of CXCR2 profoundly suppresses metastases and will increase immunotherapy in pancreatic ductal adenocarcinoma. Most cancers Cell 29, 832-845 (2016).

11

Ethier, J.L., Desautels D., Templeton A., Shah, P.S. and Amir, E. Prognostic function of the neutrophil / lymphocyte ratio in breast most cancers: systematic assessment and meta-analysis. Breast most cancers Res. 19.2 (2017).

12

Cooks, T. et al. The p53 mutant prolongs NF-κB activation and promotes power irritation and colorectal most cancers related to irritation. Most cancers Cell 23, 634-646 (2013).

13

Schwitalla, S. et al. The lack of p53 within the enterocytes generates an inflammatory microenvironment permitting invasion and lymph node metastasis of colorectal tumors induced by the carcinogen. Most cancers Cell 23, 93-106 (2013).

14

Stodden, G. R. et al. The lack of Cdh1 and Trp53 within the uterus induces power irritation with modification of the tumor microenvironment. Oncogene 34, 2471-2482 (2015).

15

Wörmann, S. M. et al. The lack of p53 operate prompts JAK2 – STAT3 signaling to advertise pancreatic tumor progress, stromal modification and resistance to gemcitabine in mice and is related to affected person survival. Gastroenterology 151, 180-193 (2016).

16

Bezzi, M. et al. Varied genetic immune landscapes dictate the development of the tumor by distinct mechanisms. Nat. Med. 24, 165-175 (2018).

17

Kersten, Ok. et al. CCL2-derived mammary tumor enhances pro-metastatic systemic irritation by upregulating IL1β in tumor-associated macrophages. OncoImmunology 6, e1334744 (2017).

18

Annunziato, S. et al. Modeling invasive lobular breast most cancers by modifying the CRISPR / Cas9-mediated somatic genome of the mammary gland. Genes Dev. 30, 1470-1480 (2016).

19

Track, X. et al. CD11b + / Gr-1 + immature myeloid cells mediate T cell suppression in mice bearing IL-1β secreting cell tumors. J. Immunol. 175, 8200-8208 (2005).

20

Singh, V., Holla, S., Ramachandra, S.G. and Balaji, Ok. N. WNT-inflammasome signaling is concerned within the growth of NOD2-induced acute arthritis in mice. J. Immunol. 194, 3351-3360 (2015).

21

Spranger, S., Bao, R. & Gajewski, T. F. The signaling of β-catenin intrinsic to melanoma prevents anti-tumor immunity. Nature 523, 231-235 (2015).

22

Avgustinova, A. et al. Wnt7a, derived from tumor cells, recruits and prompts fibroblasts to advertise the aggressiveness of the tumor. Nat. Widespread. 7, 10305 (2016).

23

Luke, J., Bao, R., Sweis, R.F., Spranger, S. and Gajewski, T.F. The activation of the WNT / β-catenin pathway correlates with immune exclusion for human cancers. Clin. Most cancers Res. 25, 3074-3083 (2019).

24

Kim, N.H. et al. p53 and microRNA-34 are suppressors of Wnt canonical signaling. Sci. Sign. four, ra71 (2011).

25

Nusse, R. & Clevers, H. Wnt / β-catenin signaling, illness and rising therapeutic modalities. Cell 169, 985-999 (2017).

26

Wellenstein, M.D. & Visser, Ok. E. Mechanisms intrinsic to most cancers cells that form the immune panorama of tumors. Immunity 48, 399-416 (2018).

27

Boggio, Ok. et al. Interleukin-12-mediated prevention of spontaneous mammary adenocarcinomas in two Her-2 / neu transgenic mouse strains. J. Exp. Med. 188, 589-596 (1998).

28

Jonkers, J. et al. Synergistic tumor suppressor exercise of BRCA2 and p53 in a conditional mouse mannequin for breast most cancers. Nat. Broom. 29, 418-425 (2001).

29

Derksen, P.W. et al. The somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular breast carcinoma by induction of resistance to anoikis and angiogenesis. Most cancers Cell 10, 437-449 (2006).

30

Liu, X. et al. The somatic lack of BRCA1 and p53 in mice induces mammary tumors exhibiting the traits of human BRCA1-like basal breast most cancers. Proc. Natl Acad. Sci. USA 104, 12111-12116 (2007).

31.

Henneman, L. et al. Selective resistance to olaparib, a PARP inhibitor, in a mouse mannequin for metaplastic breast most cancers poor in BRCA1. Proc. Natl Acad. Sci. USA 112, 8409-8414 (2015).

32

Huijbers, I.J. et al. Utilizing the GEMM-ESC technique to check the operate of genes in murine fashions. Nat. Protocols 10, 1755-1785 (2015).

33

Kas, S. M. et al. Insertion mutagenesis identifies the drivers of a brand new oncogenic pathway in invasive lobular breast most cancers. Nat. Broom. 49, 1219-1230 (2017).

34

Annunziato, S. et al. Comparative oncogenomics identifies mixtures of conductive genes and drug targets in BRCA1 -mediated breast most cancers. Nat. Widespread. 10, 397 (2019).

35

Liu, J. et al. Goal most cancers brought on by Wnt via the inhibition of Porcupine by LGK974. Proc. Natl Acad. Sci. USA 110, 20224-20229 (2013).

36

Doornebal, C. W. et al. Preclinical mouse mannequin of invasive metastases of lobular breast most cancers. Most cancers Res. 73, 353-363 (2013).

37

Sanjana, N.E., Shalem, O. and Zhang, F. Enhanced Vectors and Genome-wide Libraries for CRISPR Screening. Nat. Strategies 11, 783-784 (2014).

38

Brinkman, E. Ok., Chen T., Amendola, M. and van Steensel, B. Straightforward quantitative analysis of genome modifying by sequence hint decomposition. Nucleic Acids Res. 42, e168 (2014).

39

Schmidt, D. et al. ChIP-seq: Use high-throughput sequencing to find protein-DNA interactions. Strategies 48, 240-248 (2009).

40

Lerdrup, M., Johansen, J.V., Agrawal-Singh, S. and Hansen, Ok. An interactive surroundings for agile evaluation and visualization of on-chip sequencing knowledge. Nat. Struct. Mol. Biol. 23, 349-357 (2016).

41

Okada, N. et al. Optimistic suggestions between p53 and miR-34 miRNA mediates tumor suppression. Genes Dev. 28, 438-450 (2014).

42

Kim, D. et al. TopHat2: Correct alignment of transcriptomes within the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).

43

Trapnell, C., Pachter, L. and Salzberg, S. L. TopHat: Discovery of splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).

44

Anders, S., Pyl, P.T. and Huber, W. HTSeq: a Python framework for working with excessive throughput sequencing knowledge. Bioinformatics 31, 166-169 (2015).

45

Robinson, M.D., McCarthy, D.J. & Smyth, G.Ok. edgeR: a bioconductive software program package deal for the evaluation of differential expression of digital gene expression knowledge. Bioinformatics 26, 139-140 (2010).

46

Regulation, C. W., Chen, Y., Shi, W. and Smyth, G. Ok. voom: Precision Weights Unblock Linear Mannequin Evaluation Instruments for RNA-seq Reads Counts. Genome Biol. 15, R29 (2014).

47

Liberzon, A. et al. The attribute gene assortment of the molecular signatures database (MSigDB). Cell Syst. 1, 417-425 (2015).

48.

Bouaoun, L. et al. TP53 Variations in Human Cancers: New Classes from the IARC TP53 Database and Genomic Knowledge. Hum. Mutat. 37, 865-876 (2016).

Leave a Reply

Your email address will not be published. Required fields are marked *